المؤلفون: Jhaveri, K, Eli, LD, Wildiers, H, Hurvitz, SA, Guerrero-Zotano, A, Unni, N, Brufsky, A, Park, H, Waisman, J, Yang, ES, Spanggaard, I, Reid, S, Burkard, ME, Vinayak, S, Prat, A, Arnedos, M, Bidard, F-C, Loi, S, Crown, J, Bhave, M, Piha-Paul, SA, Suga, JM, Chia, S, Saura, C, Garcia-Saenz, JÁ, Gambardella, V, de Miguel, MJ, Gal-Yam, EN, Rapael, A, Stemmer, SM, Ma, C, Hanker, AB, Ye, D, Goldman, JW, Bose, R, Peterson, L, Bell, JSK, Frazier, A, DiPrimeo, D, Wong, A, Arteaga, CL, Solit, DB

العلاقة: pii: S0923-7534(23)00800-1; Jhaveri, K., Eli, L. D., Wildiers, H., Hurvitz, S. A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E. S., Spanggaard, I., Reid, S., Burkard, M. E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F. -C., Loi, S., Crown, J. ,. Solit, D. B. (2023). Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial. Ann Oncol, 34 (10), pp.885-898. https://doi.org/10.1016/j.annonc.2023.08.003Test.; http://hdl.handle.net/11343/337281Test

الإتاحة: https://doi.org/10.1016/j.annonc.2023.08.003Test
http://hdl.handle.net/11343/337281Test

المؤلفون: Piha-Paul SA, Dumbrava EE, Nair BC, Xiong W, Xu L, Mostorino R, Subbiah V, Tannir N, Fu S, Naing A, Janku F, Karp DD, Patel S, Daw NC, Hong D, Meric-Bernstam F, Zinner R

المصدر: OncoTargets and Therapy, Vol Volume 14, Pp 3037-3049 (2021)

مصطلحات موضوعية: crizotinib, pazopanib, vegf, alk/ros1, met, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/a-phase-i-trial-of-the-metalkros1-inhibitor-crizotinib-combined-with-t-peer-reviewed-fulltext-article-OTTTest; https://doaj.org/toc/1178-6930Test

الوصول الحر: https://doaj.org/article/ecdd833273ef4a6b981967601c3b0917Test

المؤلفون: Ott, PA, Piha-Paul, SA, Munster, P, Pishvaian, MJ, van Brummelen, EMJ, Cohen, RB, Gomez-Roca, C, Ejadi, S, Stein, M, Chan, E, Simonelli, M, Morosky, A, Saraf, S, Emancipator, K, Koshiji, M, Bennouna, J

المصدر: Annals of Oncology. 28(5)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Trials and Supportive Activities, Clinical Research, Patient Safety, Cancer, Digestive Diseases, 6.2 Cellular and gene therapies, Evaluation of treatments and therapeutic interventions, Aged, Aged, 80 and over, Anal Canal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Anus Neoplasms, Carcinoma, Squamous Cell, Disease-Free Survival, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Treatment Outcome, squamous cell advanced anal carcinoma, pembrolizumab, immunotherapy, PD-1, PD-L1, KEYNOTE-028, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/1k4632z5Test

المؤلفون: Liu, X, George, GC, Tsimberidou, AM, Naing, A, Wheler, JJ, Kopetz, S, Fu, S, Piha-Paul, SA, Eng, C, Falchook, GS, Janku, F, Garrett, C, Karp, D, Kurzrock, R, Zinner, R, Raghav, K, Subbiah, V, Hess, K, Meric-Bernstam, F, Hong, DS, Overman, MJ

المصدر: BMC Cancer. 15(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Digestive Diseases, Clinical Research, Colo-Rectal Cancer, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Cetuximab, Colorectal Neoplasms, Disease-Free Survival, ErbB Receptors, Erlotinib Hydrochloride, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Panitumumab, Proto-Oncogene Proteins p21(ras), Retreatment, Anti-EGFR treatment, KRAS-wt CRC, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis, Epidemiology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/05594475Test

المؤلفون: Piha-Paul, SA, Munster, PN, Hollebecque, A, Argilés, G, Dajani, O, Cheng, JD, Wang, R, Swift, A, Tosolini, A, Gupta, S

المصدر: European Journal of Cancer. 51(14)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Cancer, Clinical Trials and Supportive Activities, Dental/Oral and Craniofacial Disease, Rare Diseases, Administration, Oral, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Benzene Derivatives, Carcinoma, Squamous Cell, Drug Administration Schedule, Europe, Female, Head and Neck Neoplasms, Humans, Male, Maximum Tolerated Dose, Middle Aged, Molecular Targeted Therapy, Multimodal Imaging, Positron-Emission Tomography, Propionates, Protein Kinase Inhibitors, Signal Transduction, Sirolimus, Squamous Cell Carcinoma of Head and Neck, Sulfones, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, United States, Ridaforolimus, mTOR inhibitor, MK-0752, Notch inhibitor, Head and neck cancer, Phase I, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/4tk8w2hpTest

المؤلفون: Cousin, S, Blay, J-Y, Garcia, IB, de Bono, JS, Le Tourneau, C, Moreno, V, Trigo, J, Hann, CL, Azad, AA, Im, S-A, Cassier, PA, French, CA, Italiano, A, Keedy, VL, Plummer, R, Sablin, M-P, Hemming, ML, Ferron-Brady, G, Wyce, A, Khaled, A, Datta, A, Foley, SW, McCabe, MT, Wu, Y, Horner, T, Kremer, BE, Dhar, A, O'Dwyer, PJ, Shapiro, GI, Piha-Paul, SA

العلاقة: Cousin, S., Blay, J. -Y., Garcia, I. B., de Bono, J. S., Le Tourneau, C., Moreno, V., Trigo, J., Hann, C. L., Azad, A. A., Im, S. -A., Cassier, P. A., French, C. A., Italiano, A., Keedy, V. L., Plummer, R., Sablin, M. -P., Hemming, M. L., Ferron-Brady, G., Wyce, A. ,. Piha-Paul, S. A. (2021). Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study. INTERNATIONAL JOURNAL OF CANCER, 150 (6), pp.993-1006. https://doi.org/10.1002/ijc.33861Test.; http://hdl.handle.net/11343/299233Test

الإتاحة: https://doi.org/10.1002/ijc.33861Test
http://hdl.handle.net/11343/299233Test

المؤلفون: Strosberg, J, Mizuno, N, Doi, T, Grande, E, Delord, JP, Shapira-Frommer, R, Bergsland, E, Shah, M, Fakih, M, Takahashi, S, Piha-Paul, SA, O'Neil, B, Thomas, Sajeve, Lolkema, Martijn, Chen, MH, Ibrahim, N, Norwood, K, Hadoux, J

المصدر: Strosberg , J , Mizuno , N , Doi , T , Grande , E , Delord , JP , Shapira-Frommer , R , Bergsland , E , Shah , M , Fakih , M , Takahashi , S , Piha-Paul , SA , O'Neil , B , Thomas , S , Lolkema , M , Chen , MH , Ibrahim , N , Norwood , K & Hadoux , J 2020 , ' Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study ' , Clinical Cancer Research , vol. ....

الإتاحة: https://doi.org/10.1158/1078-0432.Ccr-19-3014Test
https://pure.eur.nl/en/publications/e3668b42-8157-409e-978a-d5bdf892b209Test
http://hdl.handle.net/1765/130598Test

المؤلفون: Hyman, DM, Piha-Paul, SA, Won, H, Rodon, J, Saura, C, Shapiro, GI, Juric, D, Quinn, DI, Moreno, V, Doger, B, Mayer, IA, Boni, V, Calvo, E, Loi, S, Lockhart, AC, Erinjeri, JP, Scaltriti, M, Ulaner, GA, Patel, J, Tang, J, Beer, H, Selcuklu, SD, Hanrahan, AJ, Bouvier, N, Melcer, M, Murali, R, Schram, AM, Smyth, LM, Jhaveri, K, Li, BT, Drilon, A, Harding, JJ, Iyer, G, Taylor, BS, Berger, MF, Cutler, RE, Xu, F, Butturini, A, Eli, LD, Mann, G, Farrell, C, Lalani, AS, Bryce, RP, Arteaga, CL, Meric-Bernstam, F, Baselga, J, Solit, DB

العلاقة: pii: nature25475; Hyman, D. M., Piha-Paul, S. A., Won, H., Rodon, J., Saura, C., Shapiro, G. I., Juric, D., Quinn, D. I., Moreno, V., Doger, B., Mayer, I. A., Boni, V., Calvo, E., Loi, S., Lockhart, A. C., Erinjeri, J. P., Scaltriti, M., Ulaner, G. A., Patel, J. ,. Solit, D. B. (2018). HER kinase inhibition in patients with HER2-and HER3-mutant cancers. NATURE, 554 (7691), pp.189-194. https://doi.org/10.1038/nature25475Test.; http://hdl.handle.net/11343/269701Test

الإتاحة: https://doi.org/10.1038/nature25475Test
http://hdl.handle.net/11343/269701Test

المؤلفون: Ayers, M, Lunceford, J, Nebozhyn, M, Murphy, E, Loboda, A, Kaufman, DR, Albright, A, Cheng, JD, Kang, SP, Shankaran, V, Piha-Paul, SA, Yearley, J, Seiwert, TY, Ribas, A, McClanahan, TK

المصدر: Ayers, M; Lunceford, J; Nebozhyn, M; Murphy, E; Loboda, A; Kaufman, DR; et al.(2017). IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade. JOURNAL OF CLINICAL INVESTIGATION, 127(8), 2930-2940. doi: 10.1172/JCI91190. UCLA: Retrieved from: http://www.escholarship.org/uc/item/67n460phTest

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od_______325::cf5c4ca54b3126093556d1652d13455aTest
http://www.escholarship.org/uc/item/67n460phTest

المؤلفون: Park, H, Garrido-Laguna, I, Naing, A, Fu, S, Falchook, GS, Piha-Paul, SA, Wheler, JJ, Hong, DS, Tsimberidou, AM, Subbiah, V, Zinner, RG, Kaseb, AO, Patel, S, Fanale, MA, Velez-Bravo, VM, Meric-Bernstam, F, Kurzrock, R, Janku, F

المصدر: Oncotarget, vol 7, iss 41
Park, H; Garrido-Laguna, I; Naing, A; Fu, S; Falchook, GS; Piha-Paul, SA; et al.(2016). Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. ONCOTARGET, 7(41), 67521-67531. doi: 10.18632/oncotarget.11750. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1dp7g79pTest

مصطلحات موضوعية: Sirolimus, Adult, Male, Vorinostat, Maximum Tolerated Dose, Adolescent, TOR Serine-Threonine Kinases, Oncology and Carcinogenesis, Middle Aged, phase I, Hydroxamic Acids, Histone Deacetylase Inhibitors, Young Adult, HDAC, hemic and lymphatic diseases, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, mTOR, Humans, Female, Aged

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::512319f3ff14299dfb14919f0d8072deTest
https://escholarship.org/uc/item/1dp7g79pTest